ABCT 2022
John Mezzanotte, Marcum
Jeff Solomon, Marcum
David Pritchard, OHM Dynamics
Sam Oduwole, MSK Curbsider, EMPedics
Paul Hughes, Wiggin and Dana
Ed Buckley, Ontogenics
John Mezzanotte, Marcum
Jeff Solomon, Marcum, Choukri Ben Mamoun, Virtus Therapeutics, Sam Oduwole, MSK Curbsider
Ed Buckley, Ontogenics
Sam Oduwole, MSK Curbsider, EMPedics
Tze Chaim, NAET
David Pritchard, OHM Fit
ABCT 2022
Evan Kipperman, Wiggin and Dana
Carla Devillers, Joe Vinetz, LeptoX
Evan Kipperman, Wiggin and Dana
Ellen Su, Wellinks
Jeff Solomon, Marcum
Carla Devillers, LeptoX
David Pritchard, OHM Dynamics
Joe Vinetz, LeptoX
Sam Oduwole, MSK Curbsider, EMPedics
Tze Chaim, NAET
John Mezzanotte, Marcum
Ellen Su, Wellinks
Paul Hughes, Evan Kipperman, Wiggin and Dana
Tze Chaim, NAET
Tze Chaim, NAET
Paul Hughes, Evan Kipperman, Wiggin and Dana
Joe Vinetz, LeptoX
Joe Vinetz, LeptoX
Jeff Solomon, Marcum
Ed Buckley, Ontogenics
Joe Vinetz, LeptoX
Choukri Ben Mamoun, Virtus Therapeutics
Jeff Solomon, Marcum
Ed Buckley, Ontogenics
Ellen Su, Wellinks
Accelerator for Biosciences in Connecticut
Accelerator for Biosciences in Connecticut, ABCT, is a competitive entry, 6-month long program designed for entrepreneurial research students and faculty, MBAs and MDs interested in forming new ventures in biosciences.
Accelerator for Biosciences in Connecticut encourages applications from IP-based inventions. You do not need a company formed to apply to ABCT. ABCT features a mini-MBA curriculum, expert coaching, networking, mentorship and pitch preparation support. In addition, participants have access to Venture Advisors from the program's Corporate Supporters, including Kaneka, Pfizer, Marcum, Shipman & Goodwin, WSGR, Wiggin and Dana, AON, J.P. Morgan, General Digital and Synectic, and to the NYC biosciences community including foundations and investors.
LISTEN TO AN ALUM'S EXPERIENCE
ABCT is a Program of
An intiative of
Copyright © 2020 Accelerator for Biosciences in Connecticut